- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02582957
Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome (SiVent)
November 1, 2022 updated by: University of Minnesota
A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients in intensive care units (ICUs) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation will be randomized to either usual care or usual care with the addition of sigh breaths given once every 6 minutes.
Patients will be randomized to one of the two study arms as soon as possible, but not longer than 24 hours after initiation of invasive mechanical ventilation.
Patients will be followed for 28 days to assess ventilator-free days (VFDs), mortality, ICU-free days, and the occurrence of complications.
Study Type
Interventional
Enrollment (Actual)
524
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fresno, California, United States, 93701
- UCSF Fresno Community Regional Medical Center
-
Los Angeles, California, United States, 90033
- University of Southern California (LA County)
-
Sacramento, California, United States, 95817
- University of California Davis Medical Center
-
San Diego, California, United States, 92103
- UC San Diego Medical Center
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Christiana Care Health System
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical System Shock Trauma Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
-
Missouri
-
Saint Louis, Missouri, United States, 63130
- Washington University in St. Louis
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Medical Center
-
-
Texas
-
Austin, Texas, United States, 78701
- University Medical Center Brackenridge
-
Dallas, Texas, United States, 75390
- UT Southwestern (Parkland)
-
Houston, Texas, United States, 77030
- University of Texas Medical School, Houston
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Wisconsin
-
Wauwatosa, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following:
- Traumatic brain injury
- > 1 long bone fractures
- Shock on arrival in the Emergency Department (systolic BP < 90 mmHg)
- Lung contusion
- Receipt of > 6 units of blood
Exclusion Criteria:
- Inability to obtain consent from the patient or his/her legally authorized representative (LAR)
- Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention
- Age limitations per Institutional Review Board regulations
- Undergoing invasive mechanical ventilation for > 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective
- Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints
- Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations
- Prisoners, per Human Subjects regulations
- Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint
- Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol
- Burns > 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints
- Treating physicians being unwilling to use low VT ventilation strategy when ARDS is diagnosed as low VT ventilation is now considered standard of care for patients with ARDS.
- Moribund, not expected to survive 24 hours as this could affect the clinical course and cloud interpretation of the endpoints13. Treating physician's decision to use airway pressure release ventilation (APRV).
- Patient not expected to require mechanical ventilation > 24 hours (e.g., intubated for alcohol intoxication rather than pulmonary problem).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sigh breaths
Sigh breaths consisting of a Tidal volume (VT) that produces a plateau pressure (Pplat) of 35 cmH2O (or 40 cmH2O in patients with BMIs > 35 or in patients with moderate or severe abdominal distension from ascites, blood and/or ileum, or prone patients).
The sigh breaths will be delivered once every 6 minutes, as part of usual invasive mechanical ventilation.
|
Sigh breaths delivered once every 6 minutes, as part of usual invasive mechanical ventilation.
|
No Intervention: Usual Care
Usual care, meaning that the treating physician will be free to treat the patient in any way he or she sees fit, including utilizing invasive mechanical ventilation as they wish.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ventilator-free days (VFDs)
Time Frame: 28 days
|
The difference between 28 and the day the patient was removed from any form of mechanical ventilation (i.e., invasive, non-invasive, continuous or intermittent).
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause mortality
Time Frame: 28 days
|
All-cause 28 day mortality
|
28 days
|
ICU-free days
Time Frame: 28 days
|
Number of ICU-free days to day 28 after enrollment
|
28 days
|
The occurrence of complications of treatment
Time Frame: 28 days
|
Specifically pneumothorax, ventilator-associated pneumonia, hypotension requiring pressors, pneumothorax, pneumatocele.
|
28 days
|
Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice
Time Frame: 28 days
|
Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice
|
28 days
|
Newly requiring continuous oxygen therapy at discharge
Time Frame: 28 days
|
Newly requiring continuous oxygen therapy at discharge
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard Albert, MD, University of Colorado, Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Actual)
October 8, 2022
Study Completion (Actual)
October 8, 2022
Study Registration Dates
First Submitted
October 19, 2015
First Submitted That Met QC Criteria
October 20, 2015
First Posted (Estimate)
October 21, 2015
Study Record Updates
Last Update Posted (Actual)
November 3, 2022
Last Update Submitted That Met QC Criteria
November 1, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1512M81688
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Distress Syndrome
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
University Hospital, Clermont-FerrandWithdrawn
-
China-Japan Friendship HospitalNot yet recruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress SyndromeFrance
-
Aqualung Therapeutics Corp.Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Unity Health TorontoRecruitingAcute Respiratory Distress Syndrome (ARDS)Canada, Spain, Italy, Brazil
-
Western University, CanadaEnrolling by invitationCOVID-19 Acute Respiratory Distress SyndromeCanada
-
Ain Shams UniversityCompletedCOVID-19 Acute Respiratory Distress SyndromeEgypt
-
Hospices Civils de LyonTerminatedAcute Respiratory Distress Syndrome (ARDS)France
Clinical Trials on Sigh breaths
-
Ospedale San RaffaeleActive, not recruitingRespiratory Failure | Motor Neuron Disease | Amyotrophic Lateral SclerosisItaly
-
Rigshospitalet, DenmarkUnknownRespiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia | Ventilator Induced Lung InjuryDenmark
-
Rigshospitalet, DenmarkCompletedBronchopulmonary Dysplasia | Ventilator-Induced Lung Injury | Respiratory Distress Syndrome In Premature Infants | Functional Residual CapacityAustralia
-
Zhongda HospitalRecruitingPostoperative Complications | Acute Lung Injury | Hypoxemia | Cardiac DiseaseChina
-
Prince of Songkla UniversityEnrolling by invitationHigh-Frequency VentilationThailand
-
Universidad Autonoma de Nuevo LeonUnknownInterstitial Lung Disease | COPD | Chronic Respiratory DiseaseMexico
-
Humanitas Clinical and Research CenterRecruitingCritically Ill Patients | Hemodynamic Instability | Mechanical Ventilation Pressure HighItaly
-
King's College LondonKing's College Hospital NHS TrustCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | Hot Flashes | Sleep DisordersUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...European Society of Intensive Care Medicine; University of Milano Bicocca; University...CompletedRespiratory Failure | Acute Respiratory Distress Syndrome | Ventilator LungFrance, Italy, China, Germany, Greece, Spain, United Kingdom